Though tirzepatide has not yet been approved for treatment of obesity, these results suggest that it may be more efficacious than semaglutide 2.4 mg once weekly (an approved treatment for obesity) in people without diabetes, and it approaches the effectiveness of sleeve gastrectomy
This dual mechanism is what separates tirzepatide from earlier GLP-1 receptor agonists and explains its superior weight loss results in clinical trials
The tablet is a popular choice among consumers seeking reliable skin-related solutions
Safety Information Keep it out of reach of the children
Yes, adjusting dosage or frequency can help create more stable hormone levels, which may support better sleep
Today, these medicines are transforming clinical care, delivering meaningful improvements in glycemic control and weight management, and expanding the possibilities for reducing long-term cardiometabolic risk